Technical Details:
The invention consists of low-passage cell lines generated from primary pancreatic cancers established as nude-mice xenografts, and subsequently passaged in vitro.
Looking for Partners:
Due to their low-passage, these cell lines are more representative of the alterations in the pancreatic cancer genome than existing commercial pancreatic cancer cell lines.
